Robin E, Bitran J D, Golomb H M, Newman S, Hoffman P C, Desser R K, DeMeester T R
Cancer. 1982 May 1;49(9):1916-9. doi: 10.1002/1097-0142(19820501)49:9<1916::aid-cncr2820490926>3.0.co;2-8.
Prognostic factors were examined in 38 patients with nonsmall cell lung carcinoma and brain metastases. The most important factors were the response to total therapy (corticosteroids, radiotherapy, and chemotherapy) and the presence of brain metastases alone; these factors had the most impact on survival. Age, sex, histologic type of lung cancer, and initial performance status were not prognostically important. Our results indicate that certain subgroups of patients with nonsmall cell lung carcinoma and brain metastases have a favorable prognosis and should be treated aggressively.
对38例非小细胞肺癌伴脑转移患者的预后因素进行了研究。最重要的因素是对综合治疗(皮质类固醇、放疗和化疗)的反应以及仅存在脑转移;这些因素对生存影响最大。年龄、性别、肺癌组织学类型和初始体能状态在预后方面并不重要。我们的结果表明,某些非小细胞肺癌伴脑转移患者亚组预后良好,应积极治疗。